bloomburton.comBloom Burton & Co

® X GALA CONFERENCE ® WHY BLOOM BURTON & CO? SERVICES TRANSACTIONS TEAM EVENTS News & Insights CAREERS CONTACT • M E N U • X X X ACCELERATING RETURNS IN HEALTHCARE The goal of all investors, companies and organizations is to achieve a monetizing event, such as the ability to raise capital, perform meaningful research and development, license or commercialize products, reach profitability or execute a strategic transaction. Find Out More X 2020 CONFERENCE: LATEST DEVELOPMENTS IN HEALTHCARE Bloom Burton hosts its annual Healthcare Investor Conference in Toronto, Canada. We host approximately 60 of Canada's premier publicly-traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare industry. The event attracts Canadian, U.S. and International Investors who are interested in the latest developments in Canadian healthcare. X BLOOM BURTON AWARD GALA Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada's innovative healthcare industry in the previous year. OUR SERVICES Our Services work together to identify, cultivate and create investment opportunities in the healthcare sector, on behalf of companies and investors. From start-ups through commercial launches, we are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, ife science tools, animal health, nutrition and wellness. View All Services < > < > Raising Capital & Financing From steering seed money to promising new life science ventures to facilitating private financing or raising public capital, Bloom Burton & Co. connects investors with attractive healthcare businesses poised for growth and profit. Raising Capital Raising Capital & Financing Mergers & Acquisition Advisory The mergers and acquisitions advisory capability at Bloom Burton guides clients to conceptualize, structure and execute transactions to maximize returns and company performance. Mergers & Mergers & Acquisition Advisory Equity Research Our equity analysts ask the right questions, dig deeper for answers and find details others miss. Our research division covers key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events. Equity Research Equity Research Sales & Trading Bespoke execution for healthcare institutional investors Sales & Sales & Trading Monetization Planning Understanding the business opportunities to bring healthcare advances to market, and how to successfully exploit them, are key to any company’s commercial and financial success. Monetization Planning Monetization Planning Direct Investing The Bloom Burton Investment Group exists to provide investors with curated investment vehicles that deliver a diversified portfolio of healthcare companies in a single investment. Direct Investing Direct Investing Company Creation In very special situations, instead of providing services for fees, Bloom Burton partners with entrepreneurs and researchers to form new companies, leveraging all of our services and skills to accelerate their growth. Company Creation Company Creation Project Video Project Video LATEST NEWS See All News < > 01. BNN Bloomberg | The States will be the first to market with a vaccine: Bloom Burton & Co 02. ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000 03. ESSA Pharma Announces Pricing of Public Offering of Common Shares 04. BNN Bloomberg | Moderna vaccine wont hit market until 2021: Brian Bloom 05. Q2 2020 Share Price Performance 06. CanTech Letter | Newtopia has a huge upside, says Bloom Burton 07. BNN Bloomberg | Top Canadian biopharma companies working to fight the spread of COVID-19 08. The Globe and Mail | Top Canadian biotech investor on the firms most likely to turn COVID-19 drug trials into treatments and when a vaccine may arrive 09. Antibe Therapeutics Announces Closing of $28.75 Million Bought Deal Offering 010. NMIN Welcomes Three New Board Members About Us Contact Us 2020 BLOOM BURTON & CO DESIGNED & DEVELOPED BY THE TEAM AT PIXELCARVE MEMBER IIROC MEMBER CIPF PRIVACY POLICY COMPLAINT ACCESSIBILITY POLICY BUSINESS CONTINUITY PLAN LEGAL DISCLAIMER...